HomeNGEN • CVE
add
NervGen Pharma Corp
Previous close
$2.53
Day range
$2.50 - $2.72
Year range
$1.60 - $3.98
Market cap
182.80M CAD
Avg Volume
50.69K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 7.16M | 109.51% |
Net income | -5.23M | -21.46% |
Net profit margin | — | — |
Earnings per share | -0.07 | — |
EBITDA | -7.12M | -109.29% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 21.01M | 42.09% |
Total assets | 22.46M | 37.28% |
Total liabilities | 13.28M | 18.02% |
Total equity | 9.18M | — |
Shares outstanding | 70.07M | — |
Price to book | 19.46 | — |
Return on assets | -71.07% | — |
Return on capital | -163.03% | — |
Cash Flow
Net change in cash
| (CAD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -5.23M | -21.46% |
Cash from operations | -5.75M | -302.52% |
Cash from investing | 25.23K | 118.22% |
Cash from financing | 269.74K | 272.66% |
Net change in cash | -5.55M | -327.95% |
Free cash flow | -6.72M | -945.34% |
About
Founded
2017
Headquarters
Website
Employees
10
